{"id":217,"date":"2016-06-23T12:52:22","date_gmt":"2016-06-23T19:52:22","guid":{"rendered":"https:\/\/venturaclinicaltrials.com\/?p=217"},"modified":"2016-06-28T20:30:27","modified_gmt":"2016-06-29T03:30:27","slug":"clinical-trials-ventura-ulcerative-colitis","status":"publish","type":"post","link":"https:\/\/venturaclinicaltrials.com\/?p=217","title":{"rendered":"Clinical Trials In Ventura-Ulcerative Colitis"},"content":{"rendered":"

About Dr. Sabine Hazan<\/h1>\n
\n
\"dr.<\/a>Dr. Sabine Hazan has over 22 years of experience in clinical trials and is the Founder and CEO at both Ventura Clinical Trials and Malibu Specialty Center. \u00a0As Principal Investigator, Dr. Hazan personally oversees clinical trials for high profile studies on diseases such as Hepatitis C, Hypercholesterolemia, and Pancreatic Cancer. \u00a0Her companies are leaders in Cardiovascular studies, Endocrine disorders, Infectious Diseases, Skin disorders and Gastrointestinal diseases and employ cutting edge technology and research practices to provide the best quality in drug therapy research.<\/pre>\n
The first woman ever accepted into the University of Florida as a Clinical Gastroenterology Fellow, Dr. Sabine Hazan is\u00a0a\u00a0pioneer in the medical field. \u00a0 Board certified in Gastroenterology, Hepatology, and Internal Medicine, Dr. Hazan has published articles in numerous prestigious medical journals, including theJournal of Duval County Medical Association<\/em> and Gastroenterology,\u00a0<\/em>and\u00a0won several awards, such as the Best Fellow Scientific Presentation and Dean\u2019s Research Award awarded by University of Florida. \u00a0In\u00a0addition, \u00a0Dr. Sabine Hazan is an acclaimed speaker and presented symposiums for influential medical organizations like the\u00a0American \u2028Society\u00a0for Gastrointestinal Endoscopy and Astra Merk, Inc.<\/p>\n
Dr. Sabine Hazan is the former Chief of Medicine at Community Memorial Hospital and an active consultant for CRG. \u00a0She currently retains medical licenses in three states (California, Florida, and New York).<\/p>\n
[ninja_form id=1]<\/p>\n
Personal Philosophy<\/strong><\/h2>\n
\u201cI use logic when practicing and try to think outside the box. I always remind myself that much like every fingerprint is different, every patient\u2019s symptom is different and one cannot practice like a robot. We are all humans attempting to stay a little bit longer on the planet. I never assume anything and never take anything lightly. I always try to be patient and listen and play detective with all the clues. Mostly, I realize that I am just a messenger and observe the miracles of healing that come from a higher power.<\/p>\n
Every action leads to a reaction is pure scientific thinking but the reason behind the action is unknown. We, humans are only specks on this planet who must recognize the presence of a higher power. As hard as existence is for everyone, it is just that \u201can existence for a fraction of time\u201d and as much as we come to doctors for answers we must realize that sometimes there are no answers or reason.\u201d<\/p>\n
Educational Background<\/strong><\/h2>\n
1987 \u2013 1992 DALHOUSIE UNIVERSITY, Nova Scotia, Canada<\/p>\n
MEDICAL DIPLOMA (M.D) Awarded May 1992<\/em><\/p>\n
1984 \u2013 1987 CONCORDIA UNIVERSITY, Montreal, Canada<\/p>\n
Bachelor of Sciences (BSc.) Biology Major, Physical Therapy and Minor\u00a0Nutrition<\/em><\/p>\n
1982 \u2013 1984 CEGEP BREBEUF, Montreal, Canada<\/p>\n
D.E.C. Specialty in Health, Pure & Applied Sciences<\/em><\/p>\n
Publications<\/strong>
\n1) Be R, Hazan S, Gretz J, Buckley E, Kolts BE, McGee JB, Castell DO and SR Achem.Lower Esophageal Sphincter Relaxation time: Normal values and prevalence of abnormal values in Patients with Noncardiac Chest pain and \/or dysphagia. Journal of Duval County Medical \u2028Association. \u2013 47;7;296. June 1996.<\/p>\n
2) Hazan S, Buckley F, Castell DO and Achem SR. Octreotide Improves Sensory and Pain Thresholds in Patients with Noncardiac Chest Pain. Journal of the Duval County Medical Association. 47;7;291. June 1996.<\/p>\n
3) Be R, Hazan S, Gretz J, Buckley E, Kolts BE, McGee JB, CasteLl DO an SR Achem. Lower Esophageal Sphincter Relaxation time: normal values and prevalence of abnormal values in Patients with Noncardiac Chest pain and\/or Dysphagia. Gastroenterology. April 1996;110:A6<\/p>\n<\/div>\n
Save<\/span><\/p>\n
Save<\/span><\/p>\n
Save<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"
About Dr. Sabine Hazan Dr. Sabine Hazan has over 22 years of experience in clinical trials and is the Founder and CEO at both Ventura Clinical Trials and Malibu Specialty Center. \u00a0As Principal Investigator, Dr. Hazan personally oversees clinical trials for high profile studies on diseases such as Hepatitis C, Hypercholesterolemia, and Pancreatic Cancer. \u00a0Her […]<\/p>\n","protected":false},"author":1,"featured_media":189,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,6,7],"tags":[14,8,11,9,12,13,40,44,45,43,42,41,10],"class_list":["post-217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trials","category-clinical-trials-research","category-prometheus-ulcerative-colitis","tag-clinical-doctors","tag-clinical-trials","tag-clinical-trials-recruitment","tag-clinical-trials-research","tag-prometheus-ulcerative-colitis","tag-ulcerative-colitis","tag-ulcerative-colitis-clinical-trials","tag-ulcerative-colitis-clinical-trials-in-la","tag-ulcerative-colitis-clinical-trials-in-los-angeles","tag-ulcerative-colitis-clinical-trials-in-malibu","tag-ulcerative-colitis-clinical-trials-in-oxnard","tag-ulcerative-colitis-clinical-trials-in-ventura","tag-ventura-clinical-trials","post-preview"],"_links":{"self":[{"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/posts\/217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=217"}],"version-history":[{"count":7,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/posts\/217\/revisions"}],"predecessor-version":[{"id":272,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/posts\/217\/revisions\/272"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=\/wp\/v2\/media\/189"}],"wp:attachment":[{"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/venturaclinicaltrials.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}